当前位置: 首页 > 期刊 > 《中华现代中西医杂志》 > 2000年第20期
编号:10860340
生脉注射液对化疗药物增效减毒作用研究
http://www.100md.com 《中华现代中西医杂志》 2000年第20期
生脉注射液,,生脉注射液;MTT比色法;增效作用;实验研究,1材料与方法,2结果,3讨论,【参考文献】
     【摘要】 目的 观察生脉注射液体内、外化疗增效作用。方法 体外实验采用MTT(mono-nuclear cell direct cytotoxicity assay)法,体内通过建立H22肝癌荷瘤鼠模型来观察生脉注射液联合oxaliplatin抗肿瘤活性。结果 体外研究显示oxaliplatin(大、中、小剂量)联合生脉注射液组肿瘤抑制率明显提高,分别为37.7%、39.9%和71.1%,明显高于单纯应用oxaliplatin组(20.5%、25.4%和49.0%,P<0.05),且具有较好的剂量依赖性;生脉注射液联合oxaliplatin体内可显著提高瘤重抑制率(从37.36%提高至66.90%)。结论 生脉注射液体内可提高oxaliplatin对Lovo细胞的抑制作用,体外可增强oxaliplatin的抗种植瘤效果。

    【关键词】 生脉注射液;MTT比色法;增效作用;实验研究

    In vitro and in vivo studies on the effects of Shengmai injection on efficacy enhancing of chemotherapeutic agent

    YIN Yong-xiang,CHEN Zhen,LIU Lu-ming.

    Department of TCM,Cancer Hospital,Fudan University,Shanghai 200032,China.

    【Abstract】 Objective To observe the effects of Shengmai injection on efficacy enhancing of chemotherapeutic agent oxaliplatin both in vitro and in vivo.Methods In vitro and in vivo studies on the antitumor activities of Shengmai injection combined with oxaliplatin were performed by using MTT assay and H22 hepatoma bearing mice models respectively.Results The inhibiting rates of tumor growth were improved to 37.7%,39.9% and 71.1% respectively when oxaliplatin (high ......

您现在查看是摘要页,全文长 9882 字符